Role of herbal medicines in the management of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

10.1016/j.jtcme.2022.01.002

Ansul Kumar；Arpita Rai；Mohd Saif Khan；Amit Kumar；Zeya Ul Haque；Mohammad Fazil；Gulam Rabbani

COVID-19 ； Herbal medicine ； Systematic review ； Meta-analysis

Journal of Traditional and Complementary Medicine

12卷1期（2022 / 01 / 01）

100 - 113

英文

Background and aim: The management of the worldwide spreading COVID-19 consists of amelioration of its symptoms but no cure is yet available. Herbal medicines supplemented with the Western medicine have been applied for COVID-19 treatment in India, China, Iran, and other countries. This systematic review and meta-analysis of RCTs evaluates the effect and safety of herbal intervention in the management of COVID-19. Experimental procedure: RCTs from databases like PubMed, Cochrane Library, Science Direct, Google Scholar, Science Direct, CTRI, AYUSH Research Portal, India, were reviewed and the data were extracted for study sample demographics, intervention details, clinical effect, inflammatory markers and safety monitoring. Outcomes were expressed as Risk-ratio (RR) with 95% CI for dichotomous data, and Mean- Difference (MD) with 95% CI for continuous data. Result and conclusion: From the 32 eligible studies, a total of 3177 COVID-19 patients were included in the review. Herbal intervention as an adjuvant to Western medicine causes significantly higher improvement compared to Western medicine alone [Fever (RR = 1.09 CI 1.03, 1.15), Cough (Risk- Ratio = 1.22 CI 1.08, 1.37), Fatigue (Risk-Ratio = 1.27 CI 1.11, 1.44), Chest CT Improvement (Risk- Ratio = 1.15 CI 1.08, 1.23)]. The laboratory parameters were also better in the herbal medicine group compared to standard care group only WBC (MD = 0.36 CI 0.16, 0.55), Lymphocyte percentage (MD = 5.48 CI 3.05, 7.92), Absolute lymphocyte count (MD = 0.23 CI 0.07, 0.39), CRP (MD = -5.66 CI -7.96, -3.37). However, duration of hospital stays (MD = -1.82 CI -3.84, 0.21); IL-6 (MD = -3.67 CI -8.76, 1.43), ESR Level (MD = -10.38 CI -25.96, 5.21) were statistically insignificant. No significant adverse events for herbal medications were noted in the included RCTs, during the time of the studies. (n = 665, RR 0.93; 95% CI 0.76, 1.14).

1. Mehta, P,Shah, R,Lohidasan, S,Mahadik, K(2015).Pharmacokinetic profile of phytoconstituent(s) isolated from medicinal plants-a comprehensive review.J Tradit Complement Med,5(4),207-227.
   連結：
2. WHO Coronavirus (COVID-19) Dashboard, 6th Jan https://covid19.who.int/; 2022.
3. Ahmad, A,Rai, AK,Negandhi, H(2020).Efficacy and safety of ayurveda interventions as stand-alone or adjuvant therapy in management of COVID-19: a systematic review protocol.J Res Ayurvedic Sci.,4(3),121-127.
4. Ai, XY,Lin, LP,Xie, M,Tan, XH(2020).Effect of integrated traditional Chinese and Western medicine on T lymphocyte subsets of patients with normal type of COVID-19.Guangdong Med J.,41,1203-1206.
5. Devpura, G,Tomar, B,Nathiya, D(2021).Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.Phytomedicine,84,153494.
6. Ding, XJ,Zhang, Y,He, DC(2020).Clinical effect and mechanism of Qingfei Touxie Fuzheng Recipe in the treatment of novel coronavirus pneumonia.Her Med.,39,640-644.
7. Duan, C,Xia, WG,Zheng, CJ(2020)。Clinical study on treatment of cases of COVID-19 with Jinhua Qinggan granules。J Tradit Chin Med，61，1473-1477。
8. Dutt, J,Ganatra, B,Suthar, N(2021).A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation -aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19).Contemp Clin Trials Commun,22,100755.
9. Fan, AY,Gu, S,Alemi, S(2020).Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis.J Integr Med.,18(5),385-394.
10. Fu, XX,Lin, LP,Tan, XH(2020)。Clinical study on 37 case of COVID-19 treated with integrated traditional Chinese and Western medicine。Tradit Chin Drug Res Clin Pharmacol，1，600-604。
11. Fu, XX,Lin, LP,Tan, XH(2020)。Clinical study on treatment of cases of COVID-19 with Toujie Quwen granules。Zhongguo Shi Yan Fang Ji Xue Za Zhi
12. Higgins, J,Altman, D,Gotzsche, P(2011).The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.BMJ,343(d5928)
13. Hu, K,Guan, WJ,Bi, Y(2020).Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multi-center, prospective, randomized controlled trial.Phytomedicine,16,153242.
14. Huang, H,Zhao, Y,Zuo, XH,Jin, JS,Guo, Y(2020).Treatment of COVID-19 by pneumonia No.1 prescription and pneumonia No.2 prescription.Acta Chin Med,1-11.
15. Jean, S,Lee, P,Hsueh, P(2020).Treatment options for COVID-19: the reality and challenges.J Microbiol Immunol Infect,53(3),436-443.
16. Jin, W,Lu, Y,Zhao, W,Tang, S,Sang, X,Zhang, L(2020).The efficacy of recommended treatments with integrated Chinese and Western medicine on coronavirus disease 2019 (COVID-19) in Sichuan: a clinical trial observation.Pharmacol Clin Chinese Mater Med,36,6-10.
17. Jin, X,Pang, B,Zhang, J(2019).Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID).Engineering
18. Jin, X,Pang, B,Zhang, J(2020).Core outcome set for clinical trials on coronavirus disease 2019 (COS-Covid).Engineering,6(10),1147-1152.
19. Khanna, K,Kohli, S,Kaur, R(2021).Herbal immune-boosters: substantial warriors of pandemic Covid-19 battle.Phytomedicine,85,153361.
20. Liang, S,Fang, M,Liang, C(2021).Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: a rapid systematic review and meta-analysis of randomized controlled trials.Compl Ther Med,60,102744.
21. Liao, GR(2020)。Study on the preventive effect and mortality of self-made Decoction in patients with COVID-19。Int Infect Dis，9，349。
22. Liu, M,Gao, Y,Yuan, Y(2021).Efficacy and safety of herbal medicine (Lianhua-qingwen) for treating COVID-19: a systematic review and meta-analysis.Integr Med Res,10(1),100644.
23. Liu, S,Chuang, W,Lam, W,Jiang, Z,Cheng, Y(2015).Safety surveillance of traditional Chinese medicine: current and future.Drug Saf,38(2),117-128.
24. Liu, W,Zhou, P,Chen, K(2020).Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.Can Med Assoc J.,192(27),E734-E744.
25. Liu, X,Sun, P,Qu, Z,Hu, J,Chen, C,Wu, B(2020)。Efficacy of No.1 pneumonia prescription in the treatment of corona virus disease。World Chin Med
26. Luo, X,Ni, X,Lin, J(2021).The add-on effect of Chinese herbal medicine on COVID-19: a systematic review and meta-analysis.Phytomedicine,85,153282.
27. Luo, Z,Chen, W,Xiang, M(2021).The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: a prospective randomized controlled trial.Eur J Integr Med,42,101305.
28. Maulik, M,Rao, M,Juneja, A(2021).Emerging trends from COVID-19 research registered in the clinical trials Registry - India.Indian J Med Res.,153(1),26.
29. Maurya, DK,Sharma, D(2020).Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.J Biomol Struct Dyn,1-16.
30. Mirzaie, A,Halaji, M,Dehkordi, F,Ranjbar, R,Noorbazargan, H(2020).A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).Compl Ther Clin Pract,40,101214.
31. Qiu, M,Li, QT,Zhu, DP,Wang, CH,Sun, QZ,Qian, CF(2020).Efficacy observation of maxing Xuanfei Jiedu Decoction on common type of novel coronavirus pneumonia.J Emerg Tradit Chin Med.,29,1129-1131.
32. Qu, XK,Hao, SL,Ma, JH(2020).Observation on the clinical effect of Shufeng Jiedu capsule combined with arbidol hydrochloride capsules in the treatment of COVID-19.Chin Tradit Herb Drugs,57,1167-1170.
33. Reddy, RG,Gosavi, RV,Yadav, B(2020).AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: a randomized controlled trial.AYU.,41,107-116.
34. Sardari, S,Mobaiend, A,Ghassemifard, L,Kamali, K,Khavasi, N(2021).Therapeutic effect of Thyme (Thymus Vulgaris) essential oil on patients with COVID19: a randomized clinical trial. 2021.J Adv Med Biomed Res,29(133),83-91.
35. Shi, J,Yang, Z,Ye, C(2020).Clinical observation on 49 cases of non-critical coronavirus disease 2019 in Shanghai treated by integrative traditional Chinese and western medicine.Shanghai J Tradit Chin Med,54,25-30.
36. Shi, Y,Wang, G,Cai, X(2020).An overview of COVID-19.J Zhejiang Univ - Sci B.,21(5),343-360.
37. Shiri, AH,Raiatdoost, E,Afkhami, H(2021).,未出版
38. Shukla U, Ujjaliya N, Gupta P, et al. Efficacy and safety of Guduchighan Vati in asymptomatic and mild to moderate cases of Covid-19: a randomized controlled pilot study. Preprint. 2021. https://doi.org/10.31219/osf.io/c8f9h
39. Siemieniuk, R,Bartoszko, J,Ge, L(2020).Drug treatments for covid-19: living systematic review and network meta-analysis.BMJ,370,m2980.
40. Sun, C,Sun, Y,Li, X(2020).The role of Chinese medicine in COVID-19 pneumonia: a systematic review and meta-analysis.Am J Emerg Med.,38(10),2153-2159.
41. Sun, HM,Xu, Feng,Zhang, L(2020)。Study on clinical efficacy of Lianhua Qingke Granule in treatment of mild and ordinary COVID-19。Chin J Exp Tradit Med Form，26，29-34。
42. Thakar A, Goyal M, Bhinde S, Chhotala Y, Panara K, Chaudhary S. Efficacy of ayush 64 as add-on therapy in early stage Covid 19 - an open-label randomized controlled pilot study. Preprint. 2021. https://doi.org/10.31219/osf.io/t8wza
43. Wang, G,Xiong, W,Du, J,Ai, W(2020).Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial.Integr Med Res,9(3),100489.
44. Wang, J,Wang, Z,Jing, J(2020).Exploring an integrative therapy for treating COVID-19: a randomized controlled trial.Chin J Integr Med.,26(9),648-655.
45. Wang, X,Xie, P,Sun, G(2020).A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19.Medicine,99,32.
46. Wang, Y,Han, L,Zhang, W,Sun, J(2020).The curative effect of Reduning injection combined with Xuanfeibaidu formula on COVID-19.Medicine,99,46.
47. Wu, YQ,Zou, L,Yu, X(2020).Clinical effects of integrated traditional Chinese and western medicine on COVID-19: a systematic review.Shanghai J Tradit Chin Med,1-8.
48. Xia, WG,An, CQ,Zhen, CJ(2020).Clinical study on 34 case of COVID-19 treated with integrated traditional Chinese and Western Medicine.J Tradit Chin Med,61,375-382.
49. Xiao, Q(2020).Analysis on the treatment of mild novel coronavirus pneumonia by Chinese herbal medicine Shufeng Jiedu capsules combined with arbidol.J Emerg Tradit Chin Med.,5,756-758.
50. Xiong, X,Wang, P,Su, K,Xing, Y(2020).Chinese herbal medicine for coronavirus disease 2019: a systematic review and meta-analysis.Pharmacol Res,160,105056.
51. Yang, MB,Dang, SS,Huang, S,Li, YJ,Guo, YL(2020)。Multi-center clinical observation of Reyanning mixture in treatment of novel coronavirus pneumonia。Chin J Exp Tradit Med Formul
52. Ye, Y,The G-CHAMPS Collaborative Group(2020).Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China.Front Med,7,256.
53. Yu, P,Li, YZ,Wan, SB,Wang, Y(2020)。Clinical observation of Huaqingwen Granules combined with Arbidol in the treatment of mild COVID-19 patients。Chin Pharmaceut J，55，1042-1045。
54. Zeng, M,Li, L,Wu, Z.(2020).Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): meta-analysis of randomized controlled trials.PLoS One.,15(9),e0238828.
55. Zhan, ZL,Liu, J,Yang, W(2020)。Exploratory study on evaluation criteria of Chinese medicine treatment of new coronavirus pneumonia based on case analysis。J Tradit Chin Med，1-11。
56. Zhang, CT,Yang, Y,You, F(2020)。Clinical study on COVID- 19 from the perspective of "Yidujiashi" theory。Zhong Yao Yao Li Yu Lin Chuang，36(2)，43-45。
57. Zhang, YL,Lei, L,Xu, Y(2020)。Clinical efficacy of Jinyinhua oral liquid in the treatment of 80 patients with coronavirus disease 2019。Chin Pharm，29，23-26。
58. Zhou, Fei,Ting, Yu,Du, Ronghui(2020).Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet,395,1054-1062.
59. Zhou, L,Wang, J,Xie, R(2021).The effects of traditional Chinese medicine as an auxiliary treatment for COVID-19: a systematic review and meta-analysis.J Alternative Compl Med,27(3),225-237.
60. Zhou, WM,Zhao, FM,Li, BL,Tian, ZQ(2020).The clinical value of diamine glycyrrhizin in the treatment of moderate patients with COVID-19.Chin J Virol,36,160-164.

1. Lee-Yan Sheen,Ciro Isidoro,Ashley Chiung-Fang Chang(2022).Natural products as a source of novel drugs for treating SARS-CoV2 infection.Journal of Traditional and Complementary Medicine,12(1),1-5.
2. (2024).In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation - Targeting Mpro and pan-coronavirus post-fusion Spike protein.Journal of Traditional and Complementary Medicine,14(1),55-69.